EndoTool SubQ: What You Should Know
Monarch Medical Technologies EndoTool SubQ provides clinical decision support for any situation where subcutaneous insulin is administered to all patient types, including pediatrics. This proprietary technology models, predicts and adjusts to each patient’s unique physiology and individual response to insulin.
- EndoTool will always recommend the safest, most effective patient-specific dose, beginning with the correct total daily dose and following with the precise recommended basal/bolus dose. How? EndoTool SubQ takes all factors that impact insulin response into account, including: blood glucose level, height, weight, type of diabetes mellitus, age, sex, creatinine levels, steroids, carbohydrate intake and ordered insulin.
- If a patient has low or consistently high readings, EndoTool will adjust accordingly, resulting in the reduction and elimination of correctional dosing.
- The software focuses on the most efficient and effective clinical workflow and promotes mealtime dosing in order to reduce cycling. If needed, EndoTool SubQ can accommodate another workflow, such as having to wait for the verification of carb intake.
- If at any time the nurse is concerned with the amount of insulin given due to a patient not eating as expected, the nurse may enter a new glucose. Based on the new glucose, EndoTool SubQ will recommend supplemental carbohydrates if needed.
- In the case of a patient receiving a low reading after a meal because they didn’t eat or is vomiting, EndoTool SubQ is the only platform where the algorithm will rapidly remodel and suggest additional carb recommendations prior to any hypoglycemic (BG <70 mg/dL) events.
EndoTool SubQ is changing the way we dose insulin in order to achieve better outcomes for our patients. This software provides caretakers the confidence in treating hyperglycemia while preventing hypoglycemia for an overall safer standard of care.
Related posts

News
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
We are excited to announce that Monarch Medical Technologies, the creator of EndoTool® Glucose Management System, has been acquired by Glooko, a global leader in diabetes management solutions. For EndoTool customers, nothing changes in the care and support you receive. ...

Blog
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
When clinicians ask me, "How do we move beyond standard insulin protocols and implement a glycemic management software solution without getting stuck in committee?" My answer is simple: pair clinical impact with financial clarity. Below are five practical tips I've ...

Blog
Monarch Medical Technologies Named Among TIME’s World’s Top HealthTech Companies 2025
Monarch Medical Technologies Named Among TIME’s World’s Top HealthTech Companies 2025
Innovation in patient-specific insulin dosing just earned global recognition as Monarch Medical Technologies has been recognized by TIME and Statista on their list of the World's Top HealthTech Companies 2025. This recognition underscores the impact of our mission: creating a ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields